BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 11748979)

  • 1. The clinical course of deep vein thrombosis in patients with gynecologic cancer.
    Morgan MA; Iyengar TD; Napiorkowski BE; Rubin SC; Mikuta JJ
    Gynecol Oncol; 2002 Jan; 84(1):67-71. PubMed ID: 11748979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S; Vargas CE; Kumar T; Weiner SA; Brabbins DS; Chen PY; Floyd W; Martinez AA
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis about the high risk factors and prognosis of gynecologic cancer with deep venous thrombosis].
    Huang J; Yang Z; Zhang J; Gao K; Wang H; Li L
    Zhonghua Fu Chan Ke Za Zhi; 2015 Oct; 50(10):762-9. PubMed ID: 26675576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between blood rheology, thrombosis and cancer survival in patients with gynecologic malignancy.
    von Tempelhoff GF; Nieman F; Heilmann L; Hommel G
    Clin Hemorheol Microcirc; 2000; 22(2):107-30. PubMed ID: 10831062
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian vein thrombosis: incidence of recurrent venous thromboembolism and survival.
    Wysokinska EM; Hodge D; McBane RD
    Thromb Haemost; 2006 Aug; 96(2):126-31. PubMed ID: 16894453
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Home-treatment of deep vein thrombosis in patients with cancer.
    Ageno W; Grimwood R; Limbiati S; Dentali F; Steidl L; Wells PS
    Haematologica; 2005 Feb; 90(2):220-4. PubMed ID: 15710575
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Venous thrombosis in patients with solid tumors: determination of frequency and characteristics.
    Sallah S; Wan JY; Nguyen NP
    Thromb Haemost; 2002 Apr; 87(4):575-9. PubMed ID: 12008937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of inferior vena caval filters and survival in patients with malignancy.
    Wallace MJ; Jean JL; Gupta S; Eapen GA; Johnson MM; Ahrar K; Madoff DC; Morello FA; Murthy R; Hicks ME
    Cancer; 2004 Oct; 101(8):1902-7. PubMed ID: 15386336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ovarian cancer and venous thromboembolic risk.
    Tateo S; Mereu L; Salamano S; Klersy C; Barone M; Spyropoulos AC; Piovella F
    Gynecol Oncol; 2005 Oct; 99(1):119-25. PubMed ID: 15990161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome.
    Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Treatment and prognostic factors for stage IV epithelial ovarian cancer].
    Wu M; Shen K; Lang J
    Zhonghua Fu Chan Ke Za Zhi; 2000 Apr; 35(4):200-3. PubMed ID: 11776158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deep vein thrombosis in primary care: possible malignancy?
    Oudega R; Moons KG; Karel Nieuwenhuis H; van Nierop FL; Hoes AW
    Br J Gen Pract; 2006 Sep; 56(530):693-6. PubMed ID: 16954002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-molecular-weight heparin (dalteparin) in women with gynecologic malignancy.
    DeBernardo RL; Perkins RB; Littell RD; Krasner CN; Duska LR
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1006-11. PubMed ID: 15863537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transfusion utilization during adnexal or peritoneal cancer surgery: effects on symptomatic venous thromboembolism and survival.
    Abu-Rustum NR; Richard S; Wilton A; Lev G; Sonoda Y; Hensley ML; Gemignani M; Barakat RR; Chi DS
    Gynecol Oncol; 2005 Nov; 99(2):320-6. PubMed ID: 16061278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Impact of squamous cell carcinoma antigen in patients with recurrent squamous cell carcinoma of the uterine cervix].
    Ma SK; Wu LY; Sun YC; Li B; Zhang HT
    Zhonghua Fu Chan Ke Za Zhi; 2008 Jan; 43(1):13-7. PubMed ID: 18366925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of radiation therapy for the control of Merkel cell carcinoma of the head and neck based on 36 cases and a literature review.
    Lawenda BD; Arnold MG; Tokarz VA; Silverstein JR; Busse PM; McIntyre JF; Deschler DG; Baldini EH; Kachnic LA
    Ear Nose Throat J; 2008 Nov; 87(11):634-43. PubMed ID: 19006065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic factors in neuroendocrine small cell cervical carcinoma: a multivariate analysis.
    Chan JK; Loizzi V; Burger RA; Rutgers J; Monk BJ
    Cancer; 2003 Feb; 97(3):568-74. PubMed ID: 12548598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thromboembolic complications in patients with clear cell carcinoma of the ovary.
    Matsuura Y; Robertson G; Marsden DE; Kim SN; Gebski V; Hacker NF
    Gynecol Oncol; 2007 Feb; 104(2):406-10. PubMed ID: 17014897
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Life after total laryngectomy: a measure of long-term survival, function, and quality of life.
    Woodard TD; Oplatek A; Petruzzelli GJ
    Arch Otolaryngol Head Neck Surg; 2007 Jun; 133(6):526-32. PubMed ID: 17576901
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Microscopic thrombi in glioblastoma multiforme do not predict the development of deep venous thrombosis.
    Prayson NF; Angelov L; Prayson RA
    Ann Diagn Pathol; 2009 Oct; 13(5):291-6. PubMed ID: 19751904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.